[ET Net News Agency, 11 June 2019] SSY Group Limited (02005) announced that the group
has obtained the approval for drug production and registration for Hydroxyethyl Starch
130/0.4 and Sodium Chloride Injection from the National Medical Products Administration.
Hydroxyethyl Starch 130/0.4 and Sodium Chloride Injection is under previous type 6
chemical drug. It is used in treatment or prevention of insufficient blood volume
following an assessment by doctors. (RC)